Btg Pactual Global Asset Management LTD Esperion Therapeutics, Inc. Transaction History

Btg Pactual Global Asset Management LTD

  • $600 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $355,212 - $448,243
-8,719 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$36.2 - $76.4 $53,033 - $111,926
1,465 Added 20.2%
8,719 $342,000
Q1 2018

May 15, 2018
BUY
$65.94 - $80.76 $478,328 - $585,833
7,254 New
7,254 $525,000

Others Institutions Holding ESPR

# of Institutions
206
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $153M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Btg Pactual Global Asset Management LTD Portfolio

Follow Btg Pactual Global Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email